A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C)
- PMID: 34013222
- PMCID: PMC8114613
- DOI: 10.5152/TurkArchPediatr.2020.20245
A recently explored aspect of the iceberg named COVID-19: multisystem inflammatory syndrome in children (MIS-C)
Abstract
Humanity has recently gained a novel foe named coronavirus disease 2019. Although data so far mostly suggest that children are more likely to have a favorable disease course, new concerns have been raised because of recently reported pediatric cases with hyperinflammatory conditions resembling Kawasaki disease, toxic shock syndrome, and macrophage activation syndrome/hemophagocytic lymphohistiocytosis. Because the increasing evidence suggests that this recent hyperinflammatory condition emerged in the coronavirus disease 2019 era is a distinct clinical picture, the Centers for Disease Control and Prevention named this novel disease multisystem inflammatory syndrome in children. Even if this novel disease is rare, it seems to be highly fatal. Therefore, it is urgent to understand the pathogenesis of the disease to be able to establish the appropriate treatment regimes. Concerns regarding the diagnostic process and the management of the disease have been raised even among pediatricians. Therefore, we aimed to clarify this newly occurring enigma based on the current literature and our clinical insights.
Keywords: Coronavirus disease 2019 (COVID-19); Kawasaki disease; hyperinflammatory syndrome; multisystem inflammatory syndrome in children (MIS-C); pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 infection (PIMS-TS); pediatrics; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); toxic shock syndrome.
Copyright © 2021 Turkish Pediatric Association.
Conflict of interest statement
Conflict of Interest: The authors have no conflicts of interest to declare.
Figures


Similar articles
-
Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland.Front Pediatr. 2021 May 26;9:667507. doi: 10.3389/fped.2021.667507. eCollection 2021. Front Pediatr. 2021. PMID: 34123970 Free PMC article. Review.
-
The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C).Front Med (Lausanne). 2021 Oct 28;8:747190. doi: 10.3389/fmed.2021.747190. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34778310 Free PMC article. Review.
-
Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019.Clin Exp Pediatr. 2021 Feb;64(2):68-75. doi: 10.3345/cep.2020.01900. Epub 2020 Dec 30. Clin Exp Pediatr. 2021. PMID: 33445833 Free PMC article.
-
Regression of Coronary Aneurysms With Intravenous Immunoglobulins and Steroids for COVID-19 Adult Multisystem Inflammatory Syndrome.JACC Case Rep. 2021 Apr;3(4):581-585. doi: 10.1016/j.jaccas.2021.01.012. Epub 2021 Mar 24. JACC Case Rep. 2021. PMID: 33782672 Free PMC article.
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
Cited by
-
Hematuria as an Early Sign of Multisystem Inflammatory Syndrome in Children: A Case Report of a Boy With Multiple Comorbidities and Review of Literature.Front Pediatr. 2021 Oct 27;9:760070. doi: 10.3389/fped.2021.760070. eCollection 2021. Front Pediatr. 2021. PMID: 34778150 Free PMC article.
-
Research perspective in the clinical management of Kawasaki disease.Front Pediatr. 2024 Jul 9;12:1415941. doi: 10.3389/fped.2024.1415941. eCollection 2024. Front Pediatr. 2024. PMID: 39044731 Free PMC article. Review.
-
Evaluation of 601 children with multisystem inflammatory syndrome (Turk MISC study).Eur J Pediatr. 2023 Dec;182(12):5531-5542. doi: 10.1007/s00431-023-05207-6. Epub 2023 Oct 2. Eur J Pediatr. 2023. PMID: 37782350
-
Can MIS-C develop beyond 16 weeks?Arch Rheumatol. 2021 Oct 18;37(1):150-152. doi: 10.46497/ArchRheumatol.2022.8895. eCollection 2022 Mar. Arch Rheumatol. 2021. PMID: 35949870 Free PMC article. No abstract available.
-
Readmission reasons of pediatric patients diagnosed with multisystem inflammatory syndrome after discharge.Arch Rheumatol. 2022 Oct 21;38(2):315-321. doi: 10.46497/ArchRheumatol.2023.9605. eCollection 2023 Jun. Arch Rheumatol. 2022. PMID: 37680520 Free PMC article.
References
-
- Yildiz M, Haslak F, Adrovic A, Sahin S, Barut K, Kasapcopur O. The frequency and clinical course of COVID-19 infection in children with juvenile idiopathic arthritis. Clin Exp Rheumatol. 2020;38:1271–2. - PubMed
-
- Nikolai LA, Meyer CG, Kremsner PG, Velavan TP. Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2020;100:112–6. doi: 10.1016/j.ijid.2020.08.076. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous